Novel ultra-rare exonic variants identified in a founder population implicate cadherins in schizophrenia

Todd Lencz(Feinstein Institute for Medical Research), Itsik Pe’er(Columbia University), Judy H. Cho(Cedars-Sinai Medical Center), Max Lam(Broad Institute), Susan Bressman(Icahn School of Medicine at Mount Sinai), Robert J. Klein(AdventHealth Tampa), Erin Flaherty(Columbia University), Laurie J. Ozelius(Massachusetts General Hospital), Lorraine N. Clark(Columbia University Irving Medical Center), Steven M. Lipkin(National Institutes of Health), Danny Ben‐Avraham(Albert Einstein College of Medicine), Zeynep H. Gümüş(Icahn School of Medicine at Mount Sinai), Harry Ostrer(Albert Einstein College of Medicine), Gil Atzmon(Oranim Academic College of Education), Shai Carmi(Hebrew University of Jerusalem), Inga Peter(Icahn School of Medicine at Mount Sinai), Nir Barzilai(Albert Einstein College of Medicine), Ariel Darvasi(Hebrew University of Jerusalem), Tom Maniatis(Howard Hughes Medical Institute), Jin Yu(Feinstein Institute for Medical Research), Raiyan R. Khan(Columbia University), Kenneth Offit(Memorial Sloan Kettering Cancer Center), Anil K. Malhotra(St. Michael's Hospital), Joseph Vijai(Memorial Sloan Kettering Cancer Center)
Neuron
March 23, 2021
Cited by 29


Related Papers